Salicylazosulfapyridine is the main drug for the treatment of mild and moderate ulcerative colitis, and it is characterized by its release in the colon.
In addition to its use in the treatment of ulcerative colitis, Salicylazosulfapyridine has been used in the treatment of rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and other rheumatic diseases. Sulfasalazine improves joint pain, swelling, and stiffness in patients with ankylosing spondylitis, and reduces serum IgA levels and other indicators of laboratory activity, especially for peripheral arthritis in patients with AS.
|Loss on drying||Not more than 1.0%||Conforms|
|Residue on ignition||Not more than 0.5%||Conforms|
|Assay(on dried basis)||97.0%～101.5%||Conforms|
|Appearance:||Yellow to brown powder|
Fortunachem Provides Not Only Professional Chemical Products But Also Professional Help
Keeping you up-to-date with all the latest information, news, and events about Fortunachem!